| UNCY |
Unicycive Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
9.99% |
$6.08M |
|
11.5M |
|
Great Point Partners, LLC |
Dec 31, 2024 |
| PMN |
ProMIS Neurosciences Inc. |
Common Shares, no par value per share |
9.99% |
$2.54M |
$1.12M |
5.97M |
+79.1% |
Great Point Partners, LLC |
Sep 30, 2025 |
| VTGN |
Vistagen Therapeutics, Inc. |
Common Stock, $0.001 par value per share |
6.28% |
$7.18M |
|
2.06M |
0% |
Great Point Partners, LLC |
Sep 30, 2025 |
|
Inventiva S.A. |
Ordinary shares, nominal value 0.01 Euro per share |
6.06% |
|
|
8.64M |
-18.3% |
Great Point Partners, LLC |
Sep 30, 2025 |
| ZURA |
Zura Bio Ltd |
Class A Ordinary Shares |
5.87% |
$16.5M |
$2.8M |
3.82M |
+20.4% |
Great Point Partners, LLC |
Sep 30, 2025 |
| CNTX |
Context Therapeutics Inc. |
Common Stock |
5.22% |
$4.54M |
|
4.68M |
0% |
Great Point Partners, LLC |
Sep 30, 2025 |
| OTLK |
Outlook Therapeutics, Inc. |
Common Stock, $0.001 par value per share |
4.99% |
$2.42M |
|
2.22M |
0% |
Great Point Partners, LLC |
Jun 30, 2025 |
| OPTN |
OPTINOSE, INC. |
Common Stock, $0.001 par value per share |
4.94% |
$4.74M |
-$3.33M |
526K |
-41.3% |
Great Point Partners, LLC |
Mar 31, 2025 |
| UNCY |
Unicycive Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
4.51% |
$3.47M |
|
797K |
0% |
Great Point Partners, LLC |
Sep 30, 2025 |
| NGNE |
NEUROGENE INC. |
Common Stock, par value $0.000001 per share |
2.98% |
$4.87M |
|
443K |
|
Great Point Partners, LLC |
Dec 31, 2024 |